Artificial Liver Support with CytoSorb and MARS in Liver Failure: A Retrospective Propensity Matched Analysis

医学 肝移植 重症监护室 肝病 内科学 肝衰竭 胆红素 回顾性队列研究 胃肠病学 移植
作者
Mihai Popescu,Corina David,Alexandra Marcu,Mihaela Roxana Oliță,Mariana Mihăilă,Dana Rodica Tomescu
出处
期刊:Journal of Clinical Medicine [Multidisciplinary Digital Publishing Institute]
卷期号:12 (6): 2258-2258 被引量:29
标识
DOI:10.3390/jcm12062258
摘要

Background: Liver failure represents a life-threatening organ dysfunction with liver transplantation as the only proven curable therapy to date. Liver assist devices have been extensively researched to either bridge such patients to transplantation or promote spontaneous recovery. The aim of our study was to compare two such devices, the Molecular Adsorbent Recirculating System (MARS) and CytoSorb, in patients with liver failure. Methods: We retrospectively included 15 patients who underwent MARS during their intensive care unit stay and matched them to 15 patients who underwent hemoadsorption using CytoSorb. Clinical and paraclinical data obtained after each individual session, after the course of treatment, as well as at the end of the intensive care unit stay were compared between the two groups. Results: Single sessions of CytoSorb and MARS were both associated with a significant decrease in bilirubin (p = 0.04 and p = 0.04, respectively) and ammonia levels (p = 0.04 and p = 0.04, respectively), but only CytoSorb therapy was associated with a decrease in lactate dehydrogenase levels (p = 0.04) and in platelet count (p = 0.04). After the course of treatment, only CytoSorb was associated with a significant decrease in lactate (p = 0.01), bilirubin (p = 0.01), ammonia (p = 0.02), and lactate dehydrogenase levels (p = 0.01), while patients treated with MARS did not show any improvement in paraclinical liver tests. In addition, only CytoSorb treatment was associated with a significant improvement in the Model for End-Stage Liver Disease Score (p = 0.04). Conclusion: In conclusion, our results show a potential benefit of CytoSorb in rebalancing liver functional tests in patients with liver failure compared to MARS but the exact effects on patient outcome, including hospital length of stay and survival, should be further investigated in randomized control trials.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
田様的应助被机灵幻天采纳,获得10
刚刚
刚刚
1秒前
fionawu完成签到,获得积分10
1秒前
科研通AI6.3的应助被master采纳,获得10
1秒前
4yjmngbfd完成签到,获得积分10
2秒前
LL发布了新的文献求助10
3秒前
Charming发布了新的文献求助10
3秒前
会撒娇的面包完成签到,获得积分10
4秒前
Makoto1377发布了新的文献求助10
5秒前
从此发布了新的文献求助10
5秒前
5秒前
6秒前
赘婿的应助被ki采纳,获得10
6秒前
同心源完成签到 ,获得积分20
7秒前
盗梦师完成签到 ,获得积分10
7秒前
11秒前
故渊丶发布了新的文献求助10
11秒前
li完成签到 ,获得积分10
11秒前
O耶完成签到,获得积分10
11秒前
香蕉觅云的应助被周周采纳,获得30
11秒前
11秒前
英俊的铭的应助被kjh采纳,获得10
12秒前
13秒前
秋风的应助被科研辣鸡采纳,获得10
13秒前
18秒前
12345发布了新的文献求助10
18秒前
共享精神的应助被搞怪的乐荷采纳,获得10
18秒前
19秒前
19秒前
19秒前
kk子的应助被Glllll采纳,获得20
19秒前
浮云客发布了新的文献求助10
19秒前
赤道永恒完成签到,获得积分10
21秒前
21秒前
22秒前
22秒前
霍霍发顶刊完成签到 ,获得积分10
22秒前
大个的应助被科研通管家采纳,获得10
22秒前
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183601
求助须知:如何正确求助?哪些是违规求助? 9572875
关于积分的说明 21827816
捐赠科研通 7780716
什么是DOI,文献DOI怎么找? 3434031
关于科研通互助平台的介绍 2558197
邀请新用户注册赠送积分活动 2480485